Elagolix Sodium

CHEMBL502182 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

653.6 g/mol

LogP

—

Phase

4

A salt form of elagolix, this medication reduces hormone levels that drive endometrial tissue growth, helping to relieve endometriosis-related pain. The sodium salt form supports its pharmaceutical formulation.

Masse moléculaire

653,6000 g/mol

TPSA

102,00 Å²

Aires thérapeutiques

Endometriosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+]

InChI

InChI=1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1

Molecular Formula

C32H29F5N3NaO5

HBD / HBA

1 / 11

Liaisons Rotatives

12

Atomes Lourds

46

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A salt form of elagolix, this medication reduces hormone levels that drive endometrial tissue growth, helping to relieve endometriosis-related pain. The sodium salt form supports its pharmaceutical formulation.

Yes, Elagolix Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL502182. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24785956. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Elagolix Sodium sur PillFYI

Structure

Données Clés

Formule: C32H29F5N3NaO5

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.